Product Image

Women Over 40 One Daily

MegaFood
4.8
★ ★ ★ ★ ★
(1687 ratings)
Iodine 150 mcg
Molybdenum 30 mcg
Chromium 60 mcg
Product Image
Score61
A broad one-daily formula supports basic nutrition but is not a focused energy product. The tiny listed iron amount and opaque herb blend deserve label verification.
How scoring works
Quantity:60 Tablet(s) • (60 servings)
Goals:
Energy

Score 61

A broad one-daily formula supports basic nutrition but is not a focused energy product. The tiny listed iron amount and opaque herb blend deserve label verification.
How scoring works
$37.99($0.63 per serving)
Vitacost
$ 40.13
iHerb
$ 37.99
Report prices

Analysis

B vitamins and 150 mcg of iodine support normal nutrient-to-energy metabolism and thyroid function when intake is inadequate. Vitamin D, zinc, and antioxidant vitamins add general nutritional coverage in a single tablet.

The supplied label lists only 150 mcg of iron, which is nutritionally negligible and may represent a data problem. B12 and several other energy-related nutrients are maintenance amounts, so the formula should not be expected to address significant fatigue on its own.

A 100 mg nourishing food-and-herb blend does not disclose its individual contents or doses. The product is most coherent as a basic multivitamin, with less support for users who need transparent mineral forms or targeted iron intake.

Who is it for
  • Women over 40 seeking maintenance-level one-tablet nutrition
  • Adults who do not need meaningful supplemental iron
Best for
  • General micronutrient gap coverage
  • Supporting normal energy metabolism when diet is incomplete

Pros

  • Broad vitamin and trace-mineral panel
  • Convenient one-tablet serving
  • Includes maintenance-level iodine and B vitamins

Cons

  • Listed iron amount is nutritionally negligible
  • Food-and-herb blend is opaque
  • Several yeast-associated mineral forms lack specificity

Warnings

  • Do not rely on the listed 150 mcg iron amount to correct low iron status or iron-deficiency anemia; the physical label should be checked for a possible data error.
  • Vitamin K can oppose warfarin and other vitamin-K-antagonist anticoagulants, so intake should remain consistent and medically coordinated.
  • The 150 mcg iodine amount may require medical coordination for people with thyroid disease or those using thyroid-hormone or antithyroid medicine.

Nutrient quality

64 Moderate impact

The formula offers broad maintenance coverage, but many nutrients use conventional or vaguely yeast-bound forms. The negligible listed iron amount and modest B-vitamin profile limit targeted energy support.

Ingredient transparency

55 Moderate impact

Most active amounts are listed, but the duplicate vitamin E entry and unusually small iron amount raise interpretation questions. The food-and-herb blend hides its components, and inactive tablet ingredients are absent.

Customer satisfaction

72 High impact

Aggregate customer metrics indicate strong satisfaction from a large sample. Missing feedback details prevent judging repeated complaints or whether experiences match the intended use.

Value for money

55 Moderate impact

The broad maintenance formula offers convenience but limited targeted energy value. Moderate serving cost, weak iron contribution, and an opaque blend reduce competitiveness.

Report analysis

Goals

Impact
High effect
B- Goal FitC- Strength of SupportC+ CoverageC Formula Quality
Iodine · 150 mcgVitamin D · 10 mcgVitamin B5 · 10 mgRiboflavin · 2 mgThiamin · 3 mgVitamin B12 · 10 mcgIron · 150 mcg

B vitamins and iodine provide maintenance support for nutrient-to-energy metabolism and thyroid function. The one-tablet formula offers broad coverage of common micronutrient needs.

B12, iron, and several other energy-related nutrients are too modest for targeted fatigue support, and the food blend is opaque. The product is a general nutritional foundation rather than a focused energy formula.

Study evidence
Iodine Adverse 3 studies
Iron Supportive 74 studies

Ingredients

IngredientAmount per serving
Vitamin A (Beta Carotene)
338 mcg RAE
Vitamin C (organic Orange)
60 mg
Vitamin D3 (S. cerevisiae)
10 mcg
Vitamin E (D-Alpha-Tocopherol, organic Brown Rice)
11 mg
Vitamin K (Phytonadione)
30 mcg
Thiamin (Thiamine HCl)
3 mg
Riboflavin (organic Brown Rice)
2 mg
Niacin (Niacinamide)
20 mg NE
Vitamin B6 (Pyridoxine HCl)
4 mg
Folate (Folic Acid)
400 mcg DFE
Vitamin B12 (Cyanocobalamin)
10 mcg
Biotin (organic Brown Rice)
30 mcg
Pantothenic Acid (Calcium D-Pantothenate)
10 mg
Iron (S. cerevisiae)
150 mcg
Iodine (S. cerevisiae)
150 mcg
Zinc (S. cerevisiae)
14 mg
Selenium (S. cerevisiae)
15 mcg
Copper (S. cerevisiae)
0.2 mg
Manganese (S. cerevisiae)
1 mg
Chromium (S. cerevisiae)
60 mcg
Molybdenum (S. cerevisiae)
30 mcg
Boron (S. cerevisiae)
500 mcg
Nourishing Food & Herb Blend
100 mg
Gluten Free Kosher Dairy Free Women 50+ Women 18–50 Vegetarian
Report overview
C Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyD+ Value

The iodine source is named, but it lacks the clear absorption standing of potassium iodide or well-documented kelp. The 150 mcg serving supports daily maintenance and stays below the upper limit, with elemental intake clearly stated. Moderately elevated serving cost means the broader formula must supply part of the value.

F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD- Value

The yeast-bound form lacks a defined chelating ligand, while no source branding adds quality verification. The low amount offers limited support beyond basic nutrition, and the amount remains comfortably within the safety limit. Moderate cost is undermined by the low amount.

F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The 60 mcg chromium serving is suited to nutritional maintenance rather than targeted metabolic support. Yeast-derived chromium may vary in its active chromium content, and no recognized branded source verifies consistency. The broader formula does not include a qualifying high-dose metabolic cofactor for a value adjustment.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Association of radioactive iodine treatment with survivorship symptoms and primary care utilisation in women of reproductive age with thyroid cancer: a retrospective cohort study.
    Devanarayan P; Hartman M; Partin M · Family medicine and community health · 2026
    Cohort study10,882 participantsEnergy forIodine
  2. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
    Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR · Surgery · 2020
    Cohort study2,584 participantsEnergy forIodine
  3. Health-Related Quality of Life in Differentiated Thyroid Cancer Survivors: A Cross-Sectional Study From Turkey.
    Gültekin A; Kahraman MY; Şengöz T; Şimşek FS · Head & neck · 2026
    Cross-sectional study202 participantsEnergy forIodine
  4. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
    Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT · Transfusion · 2010
    Randomized trial477 participantsEnergy forIron
  5. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
    Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K · Nutrients · 2021
    Randomized trial176 participantsEnergy forIron
  6. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
    Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J; FER-ASAP investigators · Journal of perinatal medicine · 2018
    Randomized trial252 participantsEnergy forIron
  7. Effect of iron therapy on fatigue symptoms in non-anaemic iron deficient women of reproductive age- A Randomized Controlled Trial.
    Sultana N; Bajwa FA; Sikandar MZ; Haider MM; Majeed T · JPMA. The Journal of the Pakistan Medical Association · 2026
    Randomized trial164 participantsEnergy forIron
  8. Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
    Holm C; Thomsen LL; Langhoff-Roos J · The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2019
    Randomized trial85 participantsEnergy forIron